Comparisons of two proteomic analyses of non-mucoid and mucoid Pseudomonas aeruginosa clinical isolates from a cystic fibrosis patient

被引:23
|
作者
Rao, Jayasimha [1 ]
Damron, F. Heath [1 ]
Basler, Marek [2 ]
DiGiandomenico, Antonio [1 ]
Sherman, Nicholas E. [1 ,3 ]
Fox, Jay W. [1 ,3 ]
Mekalanos, John J. [2 ]
Goldberg, Joanna B. [1 ]
机构
[1] Univ Virginia, Dept Microbiol, Hlth Sci Ctr, Charlottesville, VA 22908 USA
[2] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA
[3] Univ Virginia, Hlth Sci Ctr, WM Keck Biomed Mass Spectrometry Core, Charlottesville, VA 22908 USA
来源
基金
美国国家卫生研究院;
关键词
Pseudomonas aeruginosa; cystic fibrosis; alginate; iTRAQ; 2-DE; type; 6; secretion;
D O I
10.3389/fmicb.2011.00162
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Pseudomonas aeruginosa chronically infects the lungs of cystic fibrosis (CF) patients. The conditions in the CF lung appear to select for P aeruginosa with advantageous phenotypes for chronic infection. However, the mechanisms that allow the establishment of this chronic infection have not been fully characterized. We have previously reported the transcriptional analysis of two CF isolates strains 383 and 2192. Strain 2192 is a mucoid, alginate overproducing strain whereas strain 383 is non-mucoid. Mucoid strains are associated with chronic infection of the CF lung and non-mucoid strains are the typical initially infecting isolates. To elucidate novel differences between these two strains, we employed two methods of shotgun proteomics: isobaric tags for relative and absolute quantitation (iTRAQ) and two-dimensional gel electrophoresis (2-DE). iIRAQ compares the amount of protein between samples and relies on protein abundance, while 2-DE gel electrophoresis depends on selection of separated protein spots. For both these methods, mass spectrometry was then used to identify proteins differentially expressed between the two strains. The compilation of these two proteomic methods along with Western blot analysis revealed proteins of the HSI-I operon of the type 6 secretion system, showed increased expression in 383 compared to 2192, confirming the our previous transcriptional analysis. Proteomic analysis of other proteins did not fully correlate with the transcriptome but other differentially expressed proteins are discussed. Also, differences were noted between the results obtained for the two proteomic techniques. These shotgun proteomic analyses identified proteins that had been predicted only through gene identification; we now refer to these as "proteins of unknown functions" since their existence has now been established however their functional characterization remains to be elucidated.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 50 条
  • [21] Comparison of standard agar dilution with the Merlin, Micronaut System for automated broth microtiter antimicrobial susceptibility testing of mucoid and non-mucoid Pseudomonas aeruginosa isolates from cystic fibrosis patients
    Balke, B
    Hoy, L
    Weissbrodt, H
    Haeussler, S
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2004, 294 : 147 - 147
  • [22] Biofilm differentiation and dispersal in mucoid Pseudomonas aeruginosa isolates from patients with cystic fibrosis
    Kirov, Sylvia M.
    Webb, Jeremy S.
    O'May, Che Y.
    Reid, David W.
    Woo, Jerry K. K.
    Rice, Scott A.
    Kjelleberg, Staffan
    MICROBIOLOGY-SGM, 2007, 153 : 3264 - 3274
  • [23] Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients
    Johansen, Helle Krogh
    Moskowitz, Samuel M.
    Ciofu, Oana
    Pressler, Tacjana
    Hoiby, Niels
    JOURNAL OF CYSTIC FIBROSIS, 2008, 7 (05) : 391 - 397
  • [24] ANTIBACTERIAL ACTIVITY INVITRO OF SULBENICILLIN AGAINST MUCOID AND NON-MUCOID STRAINS OF PSEUDOMONAS-AERUGINOSA
    EFTIMIADI, C
    DELEO, C
    SCHITO, GC
    DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1985, 11 (04) : 241 - 245
  • [25] Investigation into the selection frequency of resistant mutants and the bacterial kill rate by levofloxacin and ciprofloxacin in non-mucoid Pseudomonas aeruginosa isolates from cystic fibrosis patients
    Gillespie, T
    Masterton, RG
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2002, 19 (05) : 377 - 382
  • [26] MUCOID PSEUDOMONAS-AERUGINOSA IN CYSTIC-FIBROSIS
    HENRY, RL
    DORMAN, DC
    BROWN, J
    MELLIS, C
    AUSTRALIAN PAEDIATRIC JOURNAL, 1982, 18 (01): : 43 - 45
  • [27] MUCOID PSEUDOMONAS-AERUGINOSA IN CYSTIC-FIBROSIS
    HENRY, RL
    DORMAN, DC
    BROWN, J
    MELLIS, CM
    AUSTRALIAN PAEDIATRIC JOURNAL, 1981, 17 (02): : 141 - 142
  • [28] IMMUNOLOGICAL INVESTIGATIONS OF MUCOID STRAINS OF PSEUDOMONAS-AERUGINOSA - COMPARISON OF SUSCEPTIBILITY TO OPSONIC ANTIBODY IN MUCOID AND NON-MUCOID STRAINS
    BALTIMORE, RS
    MITCHELL, M
    JOURNAL OF INFECTIOUS DISEASES, 1980, 141 (02): : 238 - 247
  • [29] EPIDEMIOLOGICAL MARKERS FOR PSEUDOMONAS-AERUGINOSA .6. RELATIONSHIP BETWEEN CONCOMITANT NON-MUCOID AND MUCOID STRAINS FROM RESPIRATORY-TRACT IN CYSTIC-FIBROSIS
    BERGAN, T
    HOIBY, N
    ACTA PATHOLOGICA ET MICROBIOLOGICA SCANDINAVICA SECTION B-MICROBIOLOGY, 1975, 83 (06): : 553 - 560
  • [30] ANTI-MICROBIAL SUSCEPTIBILITY OF MUCOID PSEUDOMONAS-AERUGINOSA AND THEIR SPONTANEOUSLY OCCURRING NON-MUCOID DERIVATIVES
    MARKOWITZ, SM
    MACRINA, FL
    PHIBBS, PV
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1980, 6 (02) : 251 - 260